Cargando…
Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
Prostate cancer recurrences are common, even with twenty-first-century primary prostate cancer treatment modalities. The most common salvage treatment is (delayed) hormonal therapy, which is often associated with serious side-effects. Due to the risk of significant toxicity, whole-gland targeted sal...
Autores principales: | Van Son, Marieke J, Peters, Max, Moerland, Marinus A, Noteboom, Juus L, Eppinga, Wietse S, Davila Fajardo, Raquel, Lagendijk, Jan, Van der Voort van Zyp, Jochem R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988341/ https://www.ncbi.nlm.nih.gov/pubmed/29876151 http://dx.doi.org/10.7759/cureus.2429 |
Ejemplares similares
-
Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients
por: van Son, Marieke, et al.
Publicado: (2020) -
Perineal recurrence of prostate cancer six years after trans-perineal brachytherapy
por: Eppinga, Wietse, et al.
Publicado: (2014) -
Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives
por: van Son, Marieke, et al.
Publicado: (2018) -
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Willigenburg, Thomas, et al.
Publicado: (2021) -
Value of Targeted Biopsies and Combined PSMA PET/CT and mp-MRI Imaging in Locally Recurrent Prostate Cancer after Primary Radiotherapy
por: Rasing, Marnix, et al.
Publicado: (2022)